SIVJEVI

Serial Number 98382883
606

Registration Progress

Application Filed
Jan 30, 2024
Under Examination
Nov 5, 2024
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SIVJEVI
Previous Owner: Pfizer Inc.
Classes: 005

Trademark Image

SIVJEVI

Basic Information

Serial Number
98382883
Filing Date
January 30, 2024
Published for Opposition
September 10, 2024
Abandonment Date
June 9, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 9, 2025
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Janina Gorbach

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Jun 9, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 9, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 30, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 30, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification

International Classes
005